Evaluation of ferric carboxymaltose treatment efficacy in women with postpartum iron deficiency anemia

Abstract

Aim: Most women in the Turkish population have iron deficiency anemia. Particularly among the pregnant women, its rateincreases. In this study, we aimed to evaluate the efficacy of intravenous ferric carboxymaltose administration in anemicwomen in the postpartum period.Material and Method: The hemoglobin (Hb) and hematocrit (Htc) values of 64 patients who received intravenous ferriccarboxymaltose treatment between January 1, 2020 and July 1, 2020 in Mardin State Hospital, Gynecology and ObstetricsClinic were retrospectively evaluated. Patients who received intravenous iron carboxymaltose treatment for postpartum irondeficiency anemia were compared after treatment. The length of stay in the hospital and whether the patient priorly receivedan erythrocyte suspension were evaluated.Results: Patients who received intravenous (IV) ferric carboxymaltose mostly due to anemia after cesarean section and normaldelivery (NSD) were included in the study. Pregnancy week and hospitalization duration means were significantly higher inthe C/S group (p